Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » Priorities for the Pharmaceutical sector in the EU

    Priorities for the Pharmaceutical sector in the EU

    inadiminadim2 July 2009 pharma
    Share
    Facebook Twitter LinkedIn Pinterest Email
    — last modified 15 July 2009

    The pharmaceutical sector is extensively regulated by the European Union in the dual interest of protecting public health while completing the single market for pharmaceuticals.


    Advertisement


    The European Union aims at completing the single market in pharmaceuticals and fostering a stable and predictable environment for pharmaceutical innovation. The main responsibilities of the European Union are:

    • to support pharmaceutical innovation in the EU;
    • to facilitate the market access of new medicines; and
    • to meet the health needs of European citizens.

    International cooperation

    Main tasks of the EU:

    • to promote international harmonisation within the International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH), and the International Conference on Harmonisation of technical requirements for registration of veterinary medicinal products (VICH);
    • to negotiate and apply mutual recognition agreements with third countries;
    • to establish bilateral dialogues with third countries, including cooperation between regulators through confidentiality arrangements; and
    • to cooperate with European and international organisations to address issues related to medicinal products.

    Source: European Commission

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    inadim

      Related Content

      Medicine Shortages in the EU – guide

      EU Commission agreement with BioNTech-Pfizer on the delivery of vaccines – guide

      Supplementary Protection Certificates – guide

      Proposal to ensure continued supply of medicines to Northern Ireland, as well as Cyprus, Ireland and Malta

      A Pharmaceutical Strategy for Europe – guide

      Supplementary protection certificate for medicinal products

      LATEST EU NEWS
      Entry exit system - Warsaw - Photo by MART PRODUCTION on Pexels

      EU’s Entry/Exit System fully operational at Schengen borders

      12 April 2026
      Trade in cars - Photo by Tom Fisk on Pexels

      EU trade deficit with China EUR 359.8 bn in 2025

      10 April 2026
      Green jobs - Photo by Gustavo Fring on Pexels

      Green jobs in EU grow by 2.2 million over last decade

      8 April 2026
      Students in Lisbon - Photo by Vytautas Markunas on Pexels

      EU offers 40,000 ‘DiscoverEU’ free travel passes to young people

      8 April 2026
      BEAK UAV drone made by Origin Robotics - Photo by Gints Ivuskans © European Union 2025

      Brussels boosts support to Ukrainian deep tech innovators

      2 April 2026

      Subscribe to EUbusiness Week

      Get the latest EU news

      CONTACT INFO

      • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
      • +44(0)20 8058 8232
      • service@eubusiness.com

      INFORMATION

      • About Us
      • Advertising
      • Contact Info

      Services

      • Cookie Policy
      • Terms
      • Disclaimer

      SOCIAL MEDIA

      Facebook
      eubusiness.com © EUbusiness Ltd 2026

      Type above and press Enter to search. Press Esc to cancel.

      Manage Consent
      To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
      Functional Always active
      The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
      Preferences
      The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
      Statistics
      The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
      Marketing
      The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
      • Manage options
      • Manage services
      • Manage {vendor_count} vendors
      • Read more about these purposes
      View preferences
      • {title}
      • {title}
      • {title}

      Sign In or Register

      Welcome Back!

      Login to your account below.

      Lost password?